Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021.
Corporate Participants:
Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions
Robert B. Ford — President and Chief Executive Officer
Robert E. Funck — Executive Vice President, Finance and Chief Financial Officer
Analysts:
Bob Hopkins — Bank of America Merrill Lynch — Analyst
Matthew Taylor — UBS — Analyst
Robert Marcus — J.P. Morgan — Analyst
David Lewis — Morgan Stanley — Analyst
Lawrence Biegelsen — Wells Fargo — Analyst
Joanne Wuensch — Citi — Analyst
Vijay Kumar — Evercore ISI — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
DG Earnings: All you need to know about Dollar General’s Q1 2023 earnings results
Dollar General Corporation (NYSE: DG) reported its first quarter 2023 earnings results today. Net sales increased 6.8% year-over-year to $9.3 billion, driven mainly by positive sales contributions from new stores and
HRL Earnings: Key highlights from Hormel Foods’ Q2 2023 financial results
Hormel Foods Corporation (NYSE: HRL) reported second quarter 2023 earnings results today. Net sales of $3 billion were down 3.8% year-over-year. Net earnings attributable to Hormel Foods Corporation were $217.2
Everything you need to know about Salesforce’s Q1 2024 financial results
Customer relationship management platform Salesforce, Inc. (NYSE: CRM) on Wednesday reported an increase in first-quarter adjusted earnings, aided by strong revenue growth. First-quarter profit, excluding non-recurring items, increased to $1.69